NCT00069251View on ClinicalTrials.gov

Bupropion for the Treatment of Methamphetamine Dependence - 1

PHASE2CompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

July 31, 2003

Study Completion Date

June 30, 2005

Conditions
Amphetamine-Related Disorders
Interventions
DRUG

Bupropion

Trial Locations (5)

50316

Powell Chemical Dependency Center, Des Moines

64108

University of Missouri - Kansas City, Kansas City

92105

South Bay Treatment Center, San Diego

92627

Matrix Institute on Addictions, Costa Mesa

96813

Pacific Addiction Research Center, Honolulu

All Listed Sponsors
lead

National Institute on Drug Abuse (NIDA)

NIH

NCT00069251 - Bupropion for the Treatment of Methamphetamine Dependence - 1 | Biotech Hunter | Biotech Hunter